Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol

British Journal of Psychiatry

Volumn 166, Issue JUNE, 1995, Pages 712-726

  Peuskens, J ^a   Donnoli, V F ^a   Portnoy, M E ^a   Stingo, N R ^a   Duarte, A ^a   Richards, M S ^a   Geretsegger, C ^a   Hebenstreit, G F ^a   Hinterhuber, H ^a   Konig, P ^a   Platz, T ^a   Puhringer, W ^a   Schony, W ^a   Schubert, H ^a   De Bleeker, E ^a   De Wilde, J ^a   Dierick, M ^a   Kindts, P ^a   Touquet, G ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARKINSONISM; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

EID: 0028865612     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.166.6.712     Document Type: Article

References (0)